Funders › MA › Charles H Hood Foundation › 2024
Grants paid by Charles H Hood Foundation, tax year 2024
EIN 04-3507847 · Manchester, MA · Form 990-PF, Part XV · NTEE T22
In tax year 2024, Charles H Hood Foundation (EIN 04-3507847) reported 22 grants paid totaling $2,470,000. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2024
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Massachusetts Institute of Technology Boston, MA | C | $4,600,000 | approved, future | HOOD PEDIATRIC INNOVATION HUB | 202533169349100728 |
| 2024 | Massachusetts Institute of Technology Boston, MA | C | $400,000 | paid | HOOD PEDIATRIC INNOVATION HUB | 202533169349100728 |
| 2024 | Yale University New Haven, CT | U | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - SUPPORTING REFUGEE MENTAL HEALTH THROUGH TRANSLATION OF EVALUATIVE INSTRUMENTS AND THROUGH A PREVENTIVE MENTAL HEALTH INTERVENTION | 202533169349100728 |
| 2024 | Boston Children's Hospital Boston, MA | U | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - ROLE OF XENOBIOTIC PATHWAYS TO MODULATE INTESTINAL EPITHELIAL METABOLISM, AS POSSIBLE TARGETS FOR OBESITY AND DIABETES | 202533169349100728 |
| 2024 | Boston Children's Hospital Boston, MA | U | $100,000 | approved, future | CHILD HEALTH RESEARCH AWARD - UNDERSTANDING MECHANISMS FOR IMPROVED PEDIATRIC SKELETAL HEALTH: NOVEL REGULATORS OF CHONDROCYTE-TO-OSTEOBLAST TRANSDIFFERENTIATION | 202533169349100728 |
| 2024 | Boston Children's Hospital Boston, MA | U | $100,000 | approved, future | CHILD HEALTH RESEARCH AWARD - NANOBODY-BASED IMMUNOTHERAPY FOR MODULATING INFLAMMATION IN JUVENILE IDIOPATHIC ARTHRITIS | 202533169349100728 |
| 2024 | Massachusetts General Hospital Boston, MA | C | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - DECIPHERING THE MECHANISM UNDERLYING SHORT- AND LONG-TERM AIRWAY HYPERRESPONSIVENESS FOLLOWING EARLY-LIFE RSV INFECTION | 202533169349100728 |
| 2024 | Massachusetts General Hospital Boston, MA | C | $100,000 | approved, future | CHILD HEALTH RESEARCH AWARD - EPIGENETIC REGULATION OF NEURAL EXCITABILITY IN A MOUSE MODEL OF INFANTILE EPILEPSY | 202533169349100728 |
| 2024 | Boston College New York, NY | U | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - IMPROVING CHILDHOOD TUBERCULOSIS TREATMENT OUTCOMES AND POST-TB LUNG FUNCTIONING AND QUALITY OF LIFE IN RURAL SOUTH AFRICA | 202533169349100728 |
| 2024 | Boston University New York, NY | U | $100,000 | approved, future | CHILD HEALTH RESEARCH AWARD - HISTONE MARKS PROFILING: DECODING CELLULAR MECHANISMS IN CONGENITAL RARE DISORDERS CAUSED BY PATHOGENIC VARIANTS IN CHROMATIN-MODIFIER GENES | 202533169349100728 |
| 2024 | Massachusetts Eye and Ear Infirmary Boston, MA | C | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - CHARACTERIZATION OF SENSORINEURAL HEARING LOSS IN NEUROFIBROMATOSIS TYPE 2 | 202533169349100728 |
| 2024 | Yale University New Haven, CT | U | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - IMPACT OF EARLY LIFE IMMUNE CHALLENGES ON BRAIN WIRING | 202533169349100728 |
| 2024 | Yale University New Haven, CT | U | $100,000 | approved, future | CHILD HEALTH RESEARCH AWARD - IMPACT OF EARLY LIFE IMMUNE CHALLENGES ON BRAIN WIRING | 202533169349100728 |
| 2024 | Massachusetts General Hospital Boston, MA | C | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - TACKLING PULMONARY HYPOPLASIA WITH GENETIC, EPIGENETIC AND STEM CELL APPROACHES. | 202533169349100728 |
| 2024 | Harvard Pilgrim Health Care Boston, MA | C | $100,000 | approved, future | CHILD HEALTH RESEARCH AWARD - SOCIOECONOMIC INEQUITIES IN RSV IMMUNIZATION AND POPULATION-BASED OUTCOMES | 202533169349100728 |
| 2024 | Boston University New York, NY | U | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - HISTONE MARKS PROFILING: DECODING CELLULAR MECHANISMS IN CONGENITAL RARE DISORDERS CAUSED BY PATHOGENIC VARIANTS IN CHROMATIN-MODIFIER GENES | 202533169349100728 |
| 2024 | Massachusetts Eye and Ear Infirmary Boston, MA | C | $100,000 | approved, future | CHILD HEALTH RESEARCH AWARD - CHARACTERIZATION OF SENSORINEURAL HEARING LOSS IN NEUROFIBROMATOSIS TYPE 2 | 202533169349100728 |
| 2024 | Boston Children's Hospital Boston, MA | U | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - CHARACTERIZING THE ROLE OF TWO SUBCORTICAL NUCLEI IN PREFRONTAL REGULATION OF ATTENTION | 202533169349100728 |
| 2024 | Dana-Farber Cancer Institute Boston, MA | C | $100,000 | approved, future | CHILD HEALTH RESEARCH AWARD - TARGETING CHROMATIN REGULATORS IN NUP98-REARRANGED ACUTE MYELOID LEUKEMIA | 202533169349100728 |
| 2024 | Boston Children's Hospital Boston, MA | U | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - UNDERSTANDING MECHANISMS FOR IMPROVED PEDIATRIC SKELETAL HEALTH: NOVEL REGULATORS OF CHONDROCYTE-TO-OSTEOBLAST TRANSDIFFERENTIATION | 202533169349100728 |
| 2024 | Harvard Pilgrim Health Care Boston, MA | C | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - SOCIOECONOMIC INEQUITIES IN RSV IMMUNIZATION AND POPULATION-BASED OUTCOMES | 202533169349100728 |
| 2024 | Massachusetts General Hospital Boston, MA | C | $100,000 | approved, future | CHILD HEALTH RESEARCH AWARD - EVALUATING EFFECTIVE COMBINATIONS OF MODIFIABLE FACTORS FOR PREVENTING YOUTH DEPRESSION RISK | 202533169349100728 |
| 2024 | Boston Children's Hospital Boston, MA | U | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - IDENTIFYING EEG-BASED BIOMARKERS OF LANGUAGE GROWTH IN PRESCHOOL-AGED CHILDREN WITH DOWN SYNDROME | 202533169349100728 |
| 2024 | Massachusetts Eye and Ear Infirmary Boston, MA | C | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - ADVANCING THE RETINOIC ACID SIGNALING ACTIVATOR AS A NOVEL THERAPEUTIC IN MOUSE MODELS OF RETINAL DEGENERATION | 202533169349100728 |
| 2024 | Harvard University Boston, MA | U | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - TARGETING LIPID DYSREGULATION IN HEREDITARY SPASTIC PARAPLEGIA | 202533169349100728 |
| 2024 | Brigham and Women's Hospital Boston, MA | C | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - THE ROLE OF MESENCHYMAL STEM CELLS TO ENHANCE IMMUNE FUNCTION IN A MODEL OF NEONATAL INFECTION | 202533169349100728 |
| 2024 | Dana-Farber Cancer Institute Boston, MA | C | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - TARGETING CHROMATIN REGULATORS IN NUP98-REARRANGED ACUTE MYELOID LEUKEMIA | 202533169349100728 |
| 2024 | Boston Children's Hospital Boston, MA | U | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - NANOBODY-BASED IMMUNOTHERAPY FOR MODULATING INFLAMMATION IN JUVENILE IDIOPATHIC ARTHRITIS | 202533169349100728 |
| 2024 | Massachusetts General Hospital Boston, MA | C | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - EPIGENETIC REGULATION OF NEURAL EXCITABILITY IN A MOUSE MODEL OF INFANTILE EPILEPSY | 202533169349100728 |
| 2024 | Boston Children's Hospital Boston, MA | U | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - POSTNATAL EXPOSURE TO HYPEROXIA CAUSES MALADAPTATION OF THE PREMATURE INTESTINE | 202533169349100728 |
| 2024 | Massachusetts General Hospital Boston, MA | C | $100,000 | paid | CHILD HEALTH RESEARCH AWARD - EVALUATING EFFECTIVE COMBINATIONS OF MODIFIABLE FACTORS FOR PREVENTING YOUTH DEPRESSION RISK | 202533169349100728 |
| 2024 | Harvard University Boston, MA | U | $100,000 | approved, future | CHILD HEALTH RESEARCH AWARD - TARGETING LIPID DYSREGULATION IN HEREDITARY SPASTIC PARAPLEGIA | 202533169349100728 |
| 2024 | Dartmouth-Hitchcock Clinic Lebanon, NH | B | $70,000 | paid | CHILD HEALTH RESEARCH AWARD - EVALUATING MECHANISMS OF ENVIRONMENTAL CHEMICAL EXPOSURE WITH DEVELOPING ZEBRAFISH URINARY SYSTEM | 202533169349100728 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.